The Expression of ARMCX1 in Gastric Cancer Contributes to Prognosis and Influences Chemotherapy

The Expression of ARMCX1 in Gastric Cancer Contributes to Prognosis and Influences Chemotherapy

The altered expression of ARMCX1 in patients with gastric cancer has been reported frequently, yet its correlation to prognosis and chemotherapy needs to be unveiled. In combination of the gene expression data retrieved from TCGA database and bioinformatic analysis, this study discovered 590 differe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Changheng Lv, Di Yang, Donghu Zhang, Jiajia Shen, Zechen Wang, Siyuan He, Lingzhang Meng, Jian Song, Jingjie Zhao
Format:	Article
Language:	English
Published:	Wiley 2023-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2023/2623317
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical Status of Cardiac Rehabilitation Manners and Models
by: Wei Wei, et al.
Published: (2022-01-01)

Timing of postoperative chemotherapy and prognosis in neoadjuvant-treated gastric cancer patients: a multicenter real-world cohort study
by: Hua-Long Zheng, et al.
Published: (2025-12-01)

Prealbumin-to-Globulin Ratio Can Predict the Chemotherapy Outcomes and Prognosis of Patients with Gastric Cancer Receiving First-Line Chemotherapy
by: Zhuo Wang, et al.
Published: (2020-01-01)

Effect of calumenin on metastasis and invasion of gastric cancer and prognosis of patients
by: REN Zhixiang, et al.
Published: (2025-03-01)

High expression of nucleobindin 2 is associated with poor prognosis in gastric cancer
by: Bolag Altan, et al.
Published: (2017-07-01)

SOX chemotherapy is effective for gastric cancer with liver metastases
by: Cong Wang, et al.
Published: (2025-05-01)

Reduced expression of uroplakin 1A is associated with the poor prognosis of gastric adenocarcinoma patients.
by: Yan Zheng, et al.
Published: (2014-01-01)

Relationship Between YWHAQ Expression and Clinicopathological Features and Prognosis of Patients with Gastric Adenocarcinoma
by: Xueqing LIU, et al.
Published: (2025-05-01)

FKBP10 expression and TP53 mutation predict prognosis and chemotherapy response in triple-negative breast cancer
by: Yan Li, et al.
Published: (2025-07-01)

Adjuvant chemotherapy for gastric cancer
by: I. P. Kolesnyk, et al.
Published: (2015-12-01)

OTX2 expression contributes progression of gastric cancer in young adults
by: Jingming Zhai, et al.
Published: (2025-05-01)

Comparison of immune checkpoint inhibitors in combination with chemotherapy versus chemotherapy alone in the first-line treatment of advanced gastric cancer patients with low PD-L1 expression: a systematic review and meta-analysis
by: Yuxin Wang, et al.
Published: (2025-05-01)

The molecular subtype based on cell cycle-related gene signature predicts the prognosis and chemotherapy and immunotherapy response in gastric cancer
by: Rishun Su, et al.
Published: (2025-07-01)

High expression of HECW1 is associated with the poor prognosis and cancer progression of gastric cancer
by: Zhihui Yang, et al.
Published: (2025-05-01)

The Characteristics, Prognosis, and Risk Factors of Lymph Node Metastasis in Early Gastric Cancer
by: Xuan Li, et al.
Published: (2018-01-01)

Investigating the Relationship between Changes in the Expression Level of the CLU Gene and the Prognosis of Gastric Cancer Patients
by: Arezoo Farhadi, et al.
Published: (2024-10-01)

Gene expression analysis of ABC transporter family in breast tumors: relationship with chemotherapy effect and disease prognosis
by: M. M. Tsyganov, et al.
Published: (2020-09-01)

A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction Adenocarcinoma
by: A. Mirza, et al.
Published: (2013-01-01)

Borderline ovarian tumors: the issues of chemotherapy and prognosis
by: I. Yu. Davydova, et al.
Published: (2015-09-01)

Research progress of gastric cancer organoids in chemotherapy drug sensitivity testing
by: Xinyi YANG, et al.
Published: (2025-08-01)

Potential Key Markers for Predicting the Prognosis of Gastric Adenocarcinoma Based on the Expression of Ferroptosis-Related lncRNA
by: Yanqun Cai, et al.
Published: (2022-01-01)

Transcatheter arterial infusion chemotherapy combined with lipiodol chemoembolization for advanced gastric fundus and cardia cancer with obstruction
by: Jiajia Zhang, et al.
Published: (2025-06-01)

DNA repair and the contribution to chemotherapy resistance
by: Ksenija Nesic, et al.
Published: (2025-05-01)

IL-36-related genes predict prognosis of gastric cancer
by: Ying Zhang, et al.
Published: (2025-06-01)

Correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with prognosis in gastric cancer patients undergoing neoadjuvant chemotherapy: a meta-analysis
by: Shuang Yang, et al.
Published: (2025-07-01)

Identifying beneficial gastric cancer patient on prognosis after treating with perioperative or postoperative-only chemotherapy: a single-center real-world study
by: Weiwei Zhu, et al.
Published: (2025-05-01)

The impact of delayed adjuvant chemotherapy on survival in gastric cancer patients with and without preoperative chemotherapy
by: Masataka Shimonosono, et al.
Published: (2025-07-01)

Associations of HLA-G 3’UTR polymorphisms and increased HLA-G expression with gastric cancer susceptibility and prognosis
by: Ines Zemni, et al.
Published: (2025-01-01)

Multiple programmed cell death patterns predict the prognosis and drug sensitivity in gastric cancer
by: Qiying Song, et al.
Published: (2025-02-01)

Analysis of systemic immunity and inflammation in the prognosis of gastric adenocarcinoma
by: G. G. Khakimova, et al.
Published: (2020-03-01)

DNMT3B Expression Might Contribute to Abnormal Methylation of RASSF1A in Lager Colorectal Adenomatous Polyps
by: Xianmei Meng, et al.
Published: (2020-01-01)

Chemotherapy Improved Prognosis of Mesenchymal Chondrosarcoma with Rare Metastasis to the Pancreas
by: Shinji Tsukamoto, et al.
Published: (2014-01-01)

A Cross-Sectional Study Comparing Mir-503-5p Expression in Gastric Cancer Patients Before and After Chemotherapy
by: Seyedeh Azra Shamsdin, et al.
Published: (2024-12-01)

THE ROLE OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER
by: A. A. Bobryshev, et al.
Published: (2021-03-01)

Tumor-associated-fibrosis and active collagen-CD44 axis characterize a poor-prognosis subtype of gastric cancer and contribute to tumor immunosuppression
by: Yingqi Yang, et al.
Published: (2025-01-01)

Variation of PPARG Expression in Chemotherapy-Sensitive Patients of Hypopharyngeal Squamous Cell Carcinoma
by: Meng Lian, et al.
Published: (2021-01-01)

High SNHG expression may contribute to poor cervical cancer prognosis, based on systematic reviews and meta-analyses
by: Zhao Zhang, et al.
Published: (2025-08-01)

Reversal of chemotherapy resistance in gastric cancer with traditional Chinese medicine as sensitizer: potential mechanism of action
by: Chencong Zhou, et al.
Published: (2025-02-01)

Overall Structural Alteration of Gut Microbiota and Relationships with Risk Factors in Patients with Metabolic Syndrome Treated with Inulin Alone and with Other Agents: An Open-Label Pilot Study
by: Ruiping Tian, et al.
Published: (2022-01-01)

Bioinformatics identification of key genes associated with the prognosis of gastric cancer
by: LIU Zhao, LIU Rui, FAN Haijing, SUN Hui, LYU Jing, ZHANG Zhen
Published: (2025-02-01)